Skip to main content
Hematology and Oncology
ALL Specialities
ALL Specialities
/
Hematology and Oncology
Blood & Cancer Podcast
CME
Diseases & Conditions
Nonmalignant Hematologic Disorders
Anemia
Bleeding Disorders
Thrombosis
Breast Cancer
CNS/Brain Cancer
Gastrointestinal Cancer
Genitourinary Cancer
Renal Cell Carcinoma
Gynecologic Cancer
Head & Neck/Thyroid Cancers
Leukemia, Myelodysplasia, Transplantation
ALL
AML
Cellular Therapy
CLL
CML
Myelodysplastic Syndrome
Transplantation
Lung Cancer
Lymphoma & Plasma Cell Disorders
B Cell Lymphoma
Follicular Lymphoma
Hodgkin Lymphoma
Mantle Cell Lymphoma
Multiple Myeloma
Non-Hodgkin Lymphoma
T Cell Lymphomas
Melanoma
Nonmelanoma Skin Cancer
Sarcoma and GIST
COVID-19 Updates
Conference Coverage
From the Journals
New clues to how air pollution fuels lung cancer in nonsmokers
Publish date:
May 4, 2023
A version of this article first appeared on
Medscape.com
.
Pages
« first
1
2
Recommended Reading
Thoracic cancer approvals differ at FDA, EMA
MDedge Hematology and Oncology
Type of insurance linked to length of survival after lung surgery
MDedge Hematology and Oncology
First target doesn’t affect survival in NSCLC with brain metastases
MDedge Hematology and Oncology
Long-term heavy smoking quadruples likelihood of lung cancer vs. less heavy smoking
MDedge Hematology and Oncology
Study gives new insight into timing of combo treatment in metastatic NSCLC
MDedge Hematology and Oncology
AFib risk with cancer drugs underestimated
MDedge Hematology and Oncology
Cancer, heart disease vaccines may be ready by 2030, Moderna says
MDedge Hematology and Oncology
Durvalumab pre, post surgery in NSCLC: Practice changing?
MDedge Hematology and Oncology
First guideline for treating oligometastatic NSCLC
MDedge Hematology and Oncology
Cancer pain declines with cannabis use
MDedge Hematology and Oncology
Lung Cancer
All Specialties
